Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Allograft
32%
Arteriovenous Fistula
11%
Autophagy
11%
Bile Duct Injury
5%
Biopsy Technique
10%
Bleeding
7%
Blood Stasis
7%
Body Mass Index
7%
Breast Cancer
5%
Cancer
12%
Cell Death
6%
Cholangiocarcinoma
19%
Cholestasis
5%
Clinical Trial
7%
Colorectal Carcinoma
5%
Colorectal Liver Metastasis
5%
Common Hepatic Artery
6%
Computer Assisted Tomography
7%
Cryoablation
5%
Cyclosporine
7%
Cytomegalovirus Infection
5%
Diabetes Mellitus
5%
Diseases
25%
End Stage Renal Disease
8%
Endothelial Cell
8%
Fistula
5%
Graft Failure
9%
Graft Survival
16%
Hazard Ratio
6%
Health Care Cost
19%
Heart Transplantation
5%
Hemodialysis
9%
Hepatectomy
26%
Hepatic Portal Vein
7%
Hepatitis C
9%
Hepatitis C Virus
9%
Hepatocellular Carcinoma
54%
Hepatocyte
13%
Human Leukocyte Antigen
5%
Image-Guided Surgery
5%
Immunosuppressive Treatment
9%
Infection
9%
Intraarterial Drug Administration
5%
Ischemia
13%
Kidney Allograft
8%
Kidney Function
5%
Kidney Graft
29%
Kidney Pancreas Transplantation
7%
Kidney Transplantation
26%
Laparoscopic Cholecystectomy
5%
Liver Cirrhosis
11%
Liver Disease
6%
Liver Function
5%
Liver Graft
53%
Liver Injury
6%
Liver Surgery
7%
Liver Transplantation
100%
Liver Tumor
6%
Living Donors
15%
Lung
6%
Machine Perfusion
10%
Magnetic Resonance Imaging
6%
Malignant Neoplasm
9%
Maturation
5%
Metastatic Carcinoma
7%
Milan Criteria
8%
Minimally Invasive Procedure
5%
Mitochondrial Permeability
8%
Model For End Stage Liver Disease Score
5%
Neoadjuvant Therapy
7%
Neoplasm
24%
Nephrectomy
6%
Odds Ratio
5%
Operating Room
5%
Oral
5%
Organ Donor
7%
Organ Transplantation
11%
Overall Survival
14%
Pancreas Transplantation
9%
Pancreaticoduodenectomy
16%
Pediatrics
17%
Positron Emission Tomography
6%
Postoperative Complication
7%
Programmed Cell Death
6%
Randomized Controlled Trial
7%
Rectum Cancer
7%
Recurrent Disease
20%
Reperfusion Injury
16%
Stenosis
5%
Surgeon
26%
Surgical Anastomosis
5%
Surgical Oncology
6%
Surgical Technique
6%
Survival Rate
9%
Tacrolimus
6%
Transplant Surgeon
6%
Transplant Surgery
7%
Tumor
19%
Vascular Access
10%
Keyphrases
Acute Rejection
9%
Allograft
15%
Apoptosis
8%
Arteriovenous Fistula
8%
Autophagy
15%
Bleeding
6%
Cadaveric
7%
Cell Death
5%
Cholangiocarcinoma
5%
Cirrhosis
11%
Clinical Outcomes
6%
Cluster of Differentiation 47 (CD47)
5%
Collagen
5%
Colorectal Cancer
6%
Colorectal Liver Metastases
5%
Computed Tomography
7%
Confidence Interval
10%
Cryoablation
8%
Cyclosporine
8%
Deceased Donor
6%
Dialysis
5%
Donation after Cardiac Death
8%
Donor Liver
7%
Downstaging
6%
Endothelial Cells
6%
Graft Function
11%
Graft Loss
7%
Graft Survival
16%
Hemostasis
7%
Hepatic Resection
11%
Hepatitis C
7%
Hepatitis C Virus
13%
Hepatocellular Carcinoma
49%
Hepatocytes
12%
High Risk
6%
Hilar Cholangiocarcinoma
6%
Human Leukocyte Antigen
7%
Image-guided Liver Surgery
8%
Immune Response
6%
Immunosuppression
11%
Interactive Images
7%
Ischemia-reperfusion Injury
27%
Kidney
20%
Kidney Transplant
9%
Kidney Transplant Recipients
5%
Kidney Transplantation
9%
Liver
51%
Liver Allograft
9%
Liver Disease
5%
Liver Resection
8%
Liver Transplant Recipients
30%
Liver Transplantation
98%
Living Donor
9%
Living Donor Kidney Transplantation
9%
Locoregional Therapy
7%
Lung
5%
MELD Score
8%
Milan Criteria
6%
Mitochondrial Dysfunction
6%
Mitochondrial Permeability Transition
12%
Normothermic Machine Perfusion
8%
North America
6%
Operative
11%
Organ Transplantation
6%
Orthotopic Liver Transplantation
18%
Overall Survival
10%
Pancreas
6%
Pancreaticoduodenectomy
15%
Patient Survival
13%
Pediatric Liver Transplantation
5%
Porcine
6%
Positron Emission Tomography
5%
Pretransplant
12%
Randomized Controlled Trial
7%
Rat Hepatocytes
6%
Readmission
6%
Renal Function
5%
Renal Transplant
7%
Renal Transplant Recipients
12%
Renal Transplantation
16%
Reperfusion
8%
Resection
23%
Risk Factors
6%
Robotics
5%
Single Center
8%
Single-center Experience
7%
Steatotic Liver
7%
Surface Registration
6%
Surgeons
17%
Surgical Oncology
6%
Surgical Technique
6%
Surgical Treatment
5%
Swine Leukocyte Antigen
6%
T Cells
5%
Tacrolimus
7%
Transplantation
39%
Tumor
15%
United States
15%
Vascular Access
7%
Xenotransplantation
8%